Refine by
Immune Response Suppliers & Manufacturers
252 companies found
based inLangenfeld, GERMANY
ARTES Biotechnology is a globally working, well established and reliable technology provider for recombinant protein production. We develop microbial cell lines and processes for vaccines, biopharmaceuticals, biosimilars and enzymes and offer ...
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
Proteins play a pivotal role in the regulation, function, and structure of various human organs and tissues. The regulation of the synthesis and degradation of proteins is crucial for cell functionality. Protein turnover can exist in three states: ...
based inREDWOOD CITY, CALIFORNIA (USA)
EnGen Bio is developing a therapy and vaccine to provide lifetime immunity to Type A flu. We´ve discovered influenza´s ¨Achille´s heel¨ Unlike conventional flu vaccines, which are generally hemagglutinin or whole-virus based, our vaccine targets a ...
While it has been believed that M1 is completely protected by the lipid membrane, we have discovered that a portion of it is in fact exposed and accessible to monoclonal antibody binding, and therefore represents a vaccine target. We have determined ...
based inVictoria, BRITISH COLUMBIA (CANADA)
Sepset Biosciences is a diagnostic company in advanced development of a blood test (Sepset-ER) for hospitals to identify patients in the emergency room (ER) who will acquire severe sepsis and have high risk for organ failure. Sepset’s test will ...
Sepset is developing a blood test for hospitals to identify septic patients in the emergency room (ER) and predict those who will have high risk for organ ...
based inDurham, NORTH CAROLINA (USA)
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable, bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. Humacyte ...
Humacyte’s platform technology has the potential to change the lives of countless people around the world by overcoming the current limitations in existing standards of care. We are leveraging our scalable technology platform to develop ...
based inShirley, NEW YORK (USA)
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems. We specialize in a range of formulation and drug delivery technologies, from ...
based inPipersville, PENNSYLVANIA (USA)
LAMPIRE specializes in custom polyclonal & monoclonal antibody development, secondary antibodies, IgGs, BSA, animal blood, tissues & organs, normal & disease state human serums & plasmas, cell media, OMNI C3 cell culture bags & contract ...
LAMPIRE began providing quality antibody support services in 1977. From antigen design and peptide synthesis to antibody purification, buffy coats (PBMCs), spleenectomies, bone marrow extractions, QC testing and labeling, our expert staff is ...
based inCham, SWITZERLAND
The global healthcare system is fundamentally changing - advances in technology such as robotics and artificial intelligence as well as rising consumer expectations are driving a global shift in the healthcare landscape. Similarly to the ...
The Combat BRS System is an innovative bladder recirculation system designed to deliver. Combat BRS is an innovative bladder recirculation system for the treatment of non muscle invasive bladder carcinomas (NMIBC) with thermotherapy and cytostatic ...
based inSeattle, WASHINGTON (USA)
We are a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, we are developing an early pipeline of innovative programs in multiple indications. ...
Novel IL-2 approaches and technologies are driving innovation in the therapeutic development space. The IL-2 pathway influences critical aspects of both immune stimulation and immune regulation, through the development and expansion of regulatory T ...
based inWichita, KANSAS (USA)
Neotherma Oncology is led by experienced healthcare executives who are working toward the dream of more effective treatments for cancer. NeoTherma Oncology is developing a groundbreaking type of radio frequency (RF) thermal treatment for deep solid ...
The energy emitted by VectRx™ increases blood perfusion in the tumor micro-environment, enhancing drug delivery, reversing treatment-resistant hypoxia, and promoting a therapeutic immune ...
based inAbingdon, UNITED KINGDOM
Thermally Stable Needle Free Solid Dose Vaccines. Enesi Pharma is developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax technologies. These diseases affect millions of ...
Infectious diseases, caused by pathogenic micro organisms, such as bacteria, viruses, parasites or fungi, are responsible for millions of deaths globally each year. Vaccines are estimated to save millions of lives each year. In addition to ...
based inDurham (RTP), NORTH CAROLINA (USA)
Jericho Sciences is developing novel antiviral therapeutics and corresponding personalized diagnostic assays which specifically address the limitations of current combination antiretroviral therapy (cART) in the clinical management of HIV-1 ...
HIV-1 is a virus that attacks the immune system in humans. It targets CD4+ T cells (a type of immune cell) that are crucial for fighting off infections. If left untreated, the virus can impair the immune system’s ability to fight off other ...
based inUppsala, SWEDEN
Olink Proteomics is a Swedish company dedicated to innovation, quality, rigor and transparency, providing outstanding products and services for human protein biomarker discovery. Our groundbreaking Olink panels for precision proteomics help ...
Casting a broader net to further explore the complexity of the human proteome. Complementing and expanding on our previous portfolio of disease area-focused biomarker panels, our exploratory panels offers scientists the chance to cast a wider net in ...
based inScottsdale, ARIZONA (USA)
Tesis Biosciences’ unique integrated medical platform is revolutionizing targeted genetic sequencing. Our mission is to change medicine by providing physicians, hospitals, and researchers with the tools to help patients treat and overcome major ...
Orthopedic Wound NGS is a comprehensive wound pathogen panel provided by Tesis Biosciences. One simple swab collection provides fast, definitive identification of targeted ...
based inNantes, FRANCE
OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases. Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics ...
CoVepiT, a multi-target and multi-variant vaccine candidate against COVID-19. CoVepiT is a next-generation multi-target, multi-variant vaccine against SARS-CoV-2 in clinical Phase 1. The vaccine candidate was designed using optimized epitopes ...
based inGaithersburg, MARYLAND (USA)
Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company’s lead product candidate, pemvidutide, is a GLP-1/glucagon dual ...
Identical vector technology used for AdCOVID (COVID-19), NasoVAX (seasonal influenza) and NasoShield (anthrax) ...
based inHertfordshire, UNITED KINGDOM
Fluidic Sciences Ltd specializes in microfluidic technologies for accelerating protein interaction analysis and single-cell screening. Their flagship product, Fluidity One-M, enables rapid measurements of binding affinity, concentration, ...
Fluidic Sciences Ltd. offers the Fluidity One-M instrument, integrated with Microfluidic Diffusional Sizing (MDS) technology, specifically engineered for in-solution analysis of antibodies and their targets throughout various stages of development. ...
based in, CALIFORNIA (USA)
AIVITA Biomedical is a biotechnology company developing personalized vaccines that target COVID-19 and the seed of all cancers using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity ...
AIVITA Biomedical is using its patient-specific vaccine platform to develop a rapidly scalable vaccine candidate, AV-COVID-19, for the novel coronavirus (SARS-CoV-2). AIVITA’s personalized vaccine begins with a basic blood draw, from which the ...
based inJincheon-gun, SOUTH KOREA
As a specialized healthcare company based on peptide technology as well as regenerative solutions, NIBEC Co., Ltd., displays expertise in the manufacture of medical devices, including dental bone grafts and tissue regenerative collagen products ...
OCS-B Xenomatrix bone graft material is bone mineral derived from bovine bone. Inflammatory organic components have been completely removed by rigorous manufacturing processes, and the structure of OCS-B Xenomatrix has a high resemblance to that of ...
based inSan Francisco, CALIFORNIA (USA)
Prellis Biologics, Inc. utilizes its proprietary, high-resolution bioprinting technology to recreate and engineer human tissues in vitro. A key application is Prellis’ Externalized Immune System, EXIS, which through the creation of lymph node ...
EXIS Human Immune Response: Prellis utilizes its proprietary holographic printing technology to engineer 3D printed lymph node organoids (LNOs) that recreates the human immunobiology in vitro allowing direct access ...